Learning in Retirement presented Psychedelic Assisted Therapy in October of 2024. Modern era clinical research with psychedelics has produced evidence that these substances, including psilocybin and MDMA, are remarkably effective in relieving a variety of mental health challenges, including anxiety and depression in patients with advanced and terminal illness. Kathryn L. Tucker is recognized as a national leader in spearheading creative and effective efforts to promote improved care for seriously ill and dying patients. She has served as Director of Advocacy at a variety of nonprofit organizations including the National Psychedelics Association. Thanks to the Panorama Auditorium staff for sharing this show.
